RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Hyperway Pharm

Hyperway Pharm

Hyperway Pharm IS A Pharmaceutical research and development production enterprise

Latest funding

$13.79M Series A ·

Source: startupintros.com

Latest round on record: Series B+, October 2026, amount undisclosed.

All 2 rounds ↓
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Health Care, Pharmaceutical.
Stage: Series B+.
Based in: Chengdu, China.
Last round: Oct 15, 2026 · 8 days ago.
Domain age: 7 years.
On Recent Funding since: Oct 20, 2026.
About Hyperway Pharm

Hyperway Pharm is a company based in Chengdu, China. Recent Funding lists it under Health and bio. It raised $13.79M in a Series A round in April 2024, according to startupintros.com. Its latest round on record is a Series B+ round in October 2026, amount undisclosed. Investors on record include BioVenture, Chengdu Future Industry Fund, Hengdian Capital, Huagai Capital and 6 others.

Funding rounds

  1. Series B+ · amount undisclosed
    Source: donews.com
  2. Series A · $13.79M
  3. Website created

Investors

Similar Health and bio companies

Questions and sources

Hyperway Pharm: questions and answers

How much has Hyperway Pharm raised?
Hyperway Pharm has raised $13.79M in one sourced round on record (Series A), announced April 22, 2024.
Who invested in Hyperway Pharm?
Investors on record for Hyperway Pharm: BioVenture, Chengdu Future Industry Fund, Hengdian Capital, Huagai Capital, IN CAPITAL, Pan-Lin Capital, Penglai Capital, Tao Capital and 2 others.
Where is Hyperway Pharm based?
Hyperway Pharm is based in Chengdu, China.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/hyperway-pharm (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy